pharmaceutical investing FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
pharmaceutical investing Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications
Prismo Metals Announces Closing of Upsized Private Placement Silver King Exploration to Begin in July
